Recent Updates
Recently added Catalysts
ARAY Positive Sentiment Score: 70/100

Accuray to Participate in Brean Capital's 2014 Life Science Conference

Monday, November 10, 2014 1 min read
Key Takeaway: Accuray Incorporated will participate in the Brean Capital 2014 Life Science Conference in New York City on November 24, 2014. The company is known for its advanced radiation oncology solutions aimed at improving patient outcomes. This event presents an opportunity for Accuray to showcase its innovations and connect with industry leaders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Accuray is participating in a notable life science conference.
  • The company is recognized for its innovative tumor treatment solutions.
  • Participation may enhance Accuray's visibility and networking opportunities.

Full Press Release Details

SUNNYVALE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) --Accuray Incorporated(Nasdaq:ARAY), announced today that its management is scheduled to participate in the Brean Capital 2014 Life Science Conference in New York City on Monday, November 24, 2014.

About Accuray

Accuray Incorporated (Nasdaq:ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visitwww.accuray.com.

Frequently Asked Questions

When is Accuray participating in the conference?

Accuray will participate in the conference on November 24, 2014.

Where is the Brean Capital conference held?

The Brean Capital conference is held in New York City.

What does Accuray specialize in?

Accuray specializes in radiation oncology and innovative tumor treatment solutions.

What is the purpose of the conference for Accuray?

The conference provides Accuray an opportunity to showcase its innovations and network.

Tags: ARAY Viatris Investor Conferences Healthcare Accuray Brean Capital Life Science Conference radiation oncology tumor treatment
Last updated: Nov 10, 2014